iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $90.63 million. The enterprise value is -$64.51 million.

Market Cap	90.63M
Enterprise Value	-64.51M

Important Dates

The next estimated earnings date is Tuesday, July 9, 2024, before market open.

Earnings Date	Jul 9, 2024
Ex-Dividend Date	n/a

Share Statistics

iHuman has 51.79 million shares outstanding.

Shares Outstanding	51.79M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.74%
Float	n/a

Valuation Ratios

The trailing PE ratio is 4.71 and the forward PE ratio is 58.14.

PE Ratio	4.71
Forward PE	58.14
PS Ratio	0.66
Forward PS	n/a
PB Ratio	0.74
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.00.

Current Ratio	2.67
Quick Ratio	2.45
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.40% and return on invested capital (ROIC) is 12.21%.

Return on Equity (ROE)	16.40%
Return on Assets (ROA)	10.70%
Return on Capital (ROIC)	12.21%
Revenue Per Employee	$175,241
Profits Per Employee	$26,530
Employee Count	783
Asset Turnover	0.71
Inventory Turnover	17.69

Taxes

In the past 12 months, iHuman has paid $2.29 million in taxes.

Income Tax	2.29M
Effective Tax Rate	9.95%

Stock Price Statistics

The stock price has decreased by -36.27% in the last 52 weeks. The beta is 0.41, so iHuman's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	-36.27%
50-Day Moving Average	1.87
200-Day Moving Average	2.33
Relative Strength Index (RSI)	49.73
Average Volume (20 Days)	17,776

Short Selling Information

Short Interest	5,082
Short Previous Month	791
Short % of Shares Out	0.01%
Short % of Float	n/a
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, iHuman had revenue of $137.21 million and earned $20.77 million in profits. Earnings per share was $0.38.

Revenue	137.21M
Gross Profit	96.80M
Operating Income	16.59M
Pretax Income	22.87M
Net Income	20.77M
EBITDA	n/a
EBIT	22.87M
Earnings Per Share (EPS)	$0.38

Full Income Statement

Balance Sheet

The company has $155.60 million in cash and $456,352 in debt, giving a net cash position of $155.14 million or $3.00 per share.

Cash & Cash Equivalents	155.60M
Total Debt	456,352
Net Cash	155.14M
Net Cash Per Share	$3.00
Equity (Book Value)	121.80M
Book Value Per Share	2.35
Working Capital	113.00M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.55%, with operating and profit margins of 12.09% and 15.14%.

Gross Margin	70.55%
Operating Margin	12.09%
Pretax Margin	16.66%
Profit Margin	15.14%
EBITDA Margin	n/a
EBIT Margin	16.66%
FCF Margin	n/a

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.76%
Shareholder Yield	0.76%
Earnings Yield	22.92%
FCF Yield	n/a

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

iHuman has an Altman Z-Score of 2.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.52
Piotroski F-Score	6